Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166
- PMID: 32535032
- PMCID: PMC7289092
- DOI: 10.1016/j.jsbmb.2020.105719
Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166
Abstract
Coronavirus infection is a serious health problem awaiting an effective vaccine and/or antiviral treatment. The major complication of coronavirus disease 2019 (COVID-19), the Acute Respiratory Distress syndrome (ARDS), is due to a variety of mechanisms including cytokine storm, dysregulation of the renin-angiotensin system, neutrophil activation and increased (micro)coagulation. Based on many preclinical studies and observational data in humans, ARDS may be aggravated by vitamin D deficiency and tapered down by activation of the vitamin D receptor. Several randomized clinical trials using either oral vitamin D or oral Calcifediol (25OHD) are ongoing. Based on a pilot study, oral calcifediol may be the most promising approach. These studies are expected to provide guidelines within a few months.
Keywords: 1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol; Acute respiratory distress syndrome (ARDS); Calcifediol or 25-hydroxyvitamin D3; Corona virus; Cytokine storm; Hypercoagulability; Lung diseases; Renin-angiotensin system; SARS-CoV-2; Vitamin D, vitamin D3 or cholecalciferol.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".J Steroid Biochem Mol Biol. 2020 Oct;203:105751. doi: 10.1016/j.jsbmb.2020.105751. Epub 2020 Aug 29. J Steroid Biochem Mol Biol. 2020. PMID: 32871238 Free PMC article. Clinical Trial.
-
Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.Ir Med J. 2020 May 7;113(5):84. Ir Med J. 2020. PMID: 32603575 No abstract available.
-
Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.Front Immunol. 2020 Sep 30;11:588724. doi: 10.3389/fimmu.2020.588724. eCollection 2020. Front Immunol. 2020. PMID: 33117402 Free PMC article.
-
Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?Am J Med Sci. 2020 Oct;360(4):338-341. doi: 10.1016/j.amjms.2020.07.018. Epub 2020 Jul 15. Am J Med Sci. 2020. PMID: 32736832 Free PMC article. Review.
-
Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol.Nutrients. 2022 Jun 29;14(13):2716. doi: 10.3390/nu14132716. Nutrients. 2022. PMID: 35807895 Free PMC article. Review.
Cited by
-
Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study.Nutrients. 2024 Jun 17;16(12):1910. doi: 10.3390/nu16121910. Nutrients. 2024. PMID: 38931265 Free PMC article.
-
[Obesity in the COVID era: A global health challenge].Endocrinol Diabetes Nutr. 2021 Feb;68(2):123-129. doi: 10.1016/j.endinu.2020.10.001. Epub 2020 Oct 21. Endocrinol Diabetes Nutr. 2021. PMID: 38620799 Free PMC article. Review. Spanish.
-
The association between vitamin D deficiency and the clinical outcomes of hospitalized COVID-19 patients.F1000Res. 2024 Feb 5;12:394. doi: 10.12688/f1000research.132214.3. eCollection 2023. F1000Res. 2024. PMID: 38434628 Free PMC article.
-
High-dose vitamin D3 supplementation shows no beneficial effects on white blood cell counts, acute phase reactants, or frequency of respiratory infections.Respir Res. 2024 Jan 4;25(1):11. doi: 10.1186/s12931-023-02642-9. Respir Res. 2024. PMID: 38178229 Free PMC article. Clinical Trial.
-
Immunomodulatory Effects of Vitamin D in Respiratory Tract Infections and COVID-19 in Children.Nutrients. 2023 Aug 2;15(15):3430. doi: 10.3390/nu15153430. Nutrients. 2023. PMID: 37571367 Free PMC article. Review.
References
-
- Bloch E.M., Shoham S., Casadevall A., Sachais B.S., Shaz B., Winters J.L., van Buskirk C., Grossman B.J., Joyner M., Henderson J.P., Pekosz A., Lau B., Wesolowski A., Katz L., Shan H., Auwaerter P.G., Thomas D., Sullivan D.J., Paneth N., Gehrie E., Spitalnik S., Hod E., Pollack L., Nicholson W.T., Pirofski L., Bailey J.A., Tobian A.A.R. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J. Clin. Invest. 2020 doi: 10.1172/jci138745. - DOI - PMC - PubMed
-
- Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., Lopez de Castilla D., Finberg R.W., Dierberg K., Tapson V., Hsieh L., Patterson T.F., Paredes R., Sweeney D.A., Short W.R., Touloumi G., Lye D.C., Ohmagari N., Oh M., Ruiz-Palacios G.M., Benfield T., Fätkenheuer G., Kortepeter M.G., Atmar R.L., Creech C.B., Lundgren J., Babiker A.G., Pett S., Neaton J.D., Burgess T.H., Bonnett T., Green M., Makowski M., Osinusi A., Nayak S., Lane H.C. Remdesivir for the treatment of Covid-19 — preliminary report. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2007764. NEJMoa2007764. - DOI - PMC - PubMed
-
- Bouillon R., Marcocci C., Carmeliet G., Bikle D., White J.H., Dawson-Hughes B., Lips P., Munns C.F., Lazaretti-Castro M., Giustina A., Bilezikian J. Skeletal and extraskeletal actions of vitamin d: current evidence and outstanding questions. Endocr. Rev. 2019;40:1109–1151. doi: 10.1210/er.2018-00126. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
